dolutegravir
FDA Grants New Indication for Dovato to Treat Adolescents 12 and Older
The FDA granted a new indication for Dovato to treat HIV-1 infection in adolescents 12 years of age and older and ...
APRIL 8, 2024
FDA Approves Dovato—First 2-Drug Complete Regimen for HIV
Dovato is a single table regimen containingdolutegravir-lamivudine and is approved as a complete regimen for the ...
APRIL 8, 2019
Dolutegravir Maintains Virologic Suppression in Multiple Trials
Dolutegravir-based regimens provide long-term suppression in HIV patients, according to presentations at the 22nd ...
JULY 26, 2018
2-Drug Combination Effective in Maintaining Viral Suppression in HIV Patients
The requirement of lifelong treatment for HIV infection has highlighted a need to minimize cumulative drug ...
FEBRUARY 17, 2017
Load more